Introduction
PPH, fibrinolysisPrior
RECRUITMENT, POSTPARTUM HAEMORRHAGE
Postpartum haemorrhage (PPH) is a leading cause of maternal mortality in most locales worldwide and third highest in high human development index (HDI) countriesTranexamic acid (TXA) is an anti-fibrinolytic compound that inhibits the conversion of plasminogen to plasmin, preventing fibrinolysisPrior to initiating a definitive trial, we aimed to conduct a pilot trial to determine the feasibility (recruitment potential, ability to adhere to study protocol) and identify potential logistical barriers. Our hypothesis for a definitive trial is that prophylactic administration of TXA (at time of shoulder delivery for spontaneous vaginal delivery or skin preparation for caesarian section) reduces the incidence of PPH associated with childbirth.